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Abstract
Advancement of biomedical applications of carbonaceous nanomaterials is hampered by their biopersistence and pro-
inflammatory action in vivo. Here, we used myeloperoxidase knockout B6.129X1-MPO (MPO k/o) mice and showed that
oxidation and clearance of single walled carbon nanotubes (SWCNT) from the lungs of these animals after pharyngeal
aspiration was markedly less effective whereas the inflammatory response was more robust than in wild-type C57Bl/6 mice.
Our results provide direct evidence for the participation of MPO – one of the key-orchestrators of inflammatory response –
in the in vivo pulmonary oxidative biodegradation of SWCNT and suggest new ways to control the biopersistence of
nanomaterials through genetic or pharmacological manipulations.
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Introduction
Biopersistence of carbon nanotubes (CNT) - resulting from their
inherent durability [1,2] is one the major stumbling blocks on the
way of their broad biomedical applications. This is because
engineered CNT represent a possible health risk due to their
ability to cause pulmonary inflammation, severe oxidative stress
and early onset fibrosis in animals [3,4,5,6]. They also exert
genotoxic effects [7] possibly associated with carcinogenesis (e.g.,
induction of mesotheliomas) [8,9]. These health concerns have
been associated – to a large extent – with the reported long ‘‘life-
span’’ of SWCNT in the lung thus necessitating exploration of
possible metabolic pathways leading to their biodegradation.
Although different types of chemical oxidative cutting of CNT
- lengthwise and shortening – have been described, they require
harsh oxidants (e.g., sulphuric acid plus H2O2 or KMnO4) [10].
Recently, we reported that reactive intermediates of horseradish
peroxidase are effective in enzymatic oxidative biodegradation of
CNT and graphene oxide [11,12,13]. Moreover, myeloperoxi-
dase (MPO), an abundant enzyme of inflammatory cells
(neutrophils), - involved in the principal defense mechanisms of
innate immunity -was also effective in oxidative biodegradation of
CNT in biochemical models and in cells yielding the products
that did not cause pulmonary inflammation in mice [14].
However, the relevance of this mechanism for CNT biodegra-
dation in vivo was lacking. Here, we employed MPO knockout
B6.129X1-MPO (MPO k/o) vs wild-type C57Bl/6 mice (w/t) and
demonstrated that clearance and oxidation of single wall carbon
nanotubes (SWCNT) in the lungs after their pharyngeal
aspiration was markedly less effective whereas inflammatory
response was more robust in the former than in the latter. Our
results provide direct evidence for the participation of MPO in
pulmonary biodegradation of SWCNT in vivo. Based on these
data, new genetic and pharmacological approaches can be
developed to regulate the biopersistence of nanomaterials in
tissues.
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Results and Discussion
Pulmonary inflammatory responses in w/t and MPO k/o
mice exposed to SWCNT
Upon pharyngeal aspiration, SWCNT elicited typical inflam-
matory responses in w/t and MPO k/o mice documented by
increased production of pro-inflammatory cytokines (TNF-a, IL-6
and MCP-1) 1 day after the exposure (Fig. 1a, b, c). BAL cytology
indicated a robust and early (day 1) accumulation of neutrophils -
slightly weaker in MPO k/o mice vs w/t animals (Fig. 1d), followed
by a sequential appearance of macrophages in both groups of
animals (with a peak at day 7) (data not shown) [4]. At day 28 post
exposure, the amounts of PMN in BAL fluid from exposed MPO
k/o mice and w/t mice are not different from those in the
respective control groups of animals (Fig. 1d). In BAL,
phagocytized SWCNT were detected inside PMNs and macro-
phages (Fig. 1e). Because of the enrichment of PMNs with MPO,
we compared the SWCNT content in these cells. An ,10 times
greater number of PMNs from MPO k/o mice had SWCNT
inclusions than those from w/t animals (Fig. 1f), in agreement with
the lack of MPO-driven biodegradation in MPO k/o mice.
Assessments of fibrosis by measurements of collagen deposition
on day 28 post-exposure revealed its significantly higher amounts
in the lungs of MPO k/o mice compared to w/t animals (Fig. 2a).
A stronger fibrogenic response in k/o vs w/t mice was also evident
from quantitative morphometry of the thickness of fibrous collagen
in the alveolar connective tissue (Fig. 2b). An increase of the
thickness was observed already at day 1 post-exposure and
progressed further by day 28 compared with air control groups. A
markedly higher collagen content of the alveolar wall was detected
Figure 1. Characterization of pulmonary inflammatory responses to SWCNT in w/t and MPO k/o mice at day 1 after pharyngeal
aspiration exposure. a–c. Levels of pro-inflammatory cytokines (a - TNF-a; b - IL-6; c – MCP-1) in BAL fluid of w/t and MPO k/o mice. Mean 6 SEM
(n = 6 mice/group). *p,0.05, vs control PBS-exposed mice. d. Content of PMNs in BAL fluid of w/t and MPO k/o mice. Mean6 SEM (n= 6 mice/group).
*p,0.05, vs control PBS-exposed mice. e. Typical microscopic images of inflammatory cells in BAL fluid with SWCNT inclusions (red arrows). f. Content
of PMNs with engulfed SWCNT in BAL fluid of w/t and MPO k/o mice. Mean 6 SEM (n= 6 mice/group). *p,0.05, vs w/t mice.
doi:10.1371/journal.pone.0030923.g001
Myeloperoxidase Clearance of Carbon Nanotubes
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e30923
in the lung of MPO-deficient mice compared to w/t animals
(Fig. 2b).
Assessment of SWCNT aggregates in the lung of w/t and
MPO k/o mice
To evaluate the content of SWCNT and their aggregates we
employed quantitative imaging by illuminating lung sections with
the light in the spectral range of 750–840 nm selectively absorbed
by SWCNT. In the images presented in Fig. 3a, the lung tissue is
shown in red, the SWCNT image was inverted such that the
nanotubes look bright and pseudocolored in green. The volume
occupied by SWCNT at day 1 post-exposure (,07–1.0% of the
total lung volume) markedly decreased by day 28 (to 0.02–0.03%).
Elimination of SWCNT from the lung of w/t mice was almost 2
times more effective than in MPO k/o animals (Fig. 3b).
Additionally, we employed another approach for collecting
SWCNT images: we scanned unstained paraffin embedded lung
sections using INCell Analyser 1000 high content screening;
optically detectable SWCNT aggregates were counted in each
field throughout the lung sections. The content of SWCNT
aggregates in each field on day 1 post-exposure was approximately
the same in both groups of mice but markedly decreased by day 28
after exposure (Fig. 3c). Assuming the content of aggregates on day
1 in both groups as 100%, the relative content of SWCNT
aggregates dropped to ,20% in w/t samples but remained at the
level of .60% in the MPO k/o lung sections – a more than 3-fold
difference.
To obtain further evidence for ‘‘cutting’’ of SWCNT by MPO,
we performed TEM analysis of the lung samples after solubiliza-
tion of the tissue and evaluated the size distribution of SWCNT
and their aggregates (Fig. 4). On day 1 after exposure, ,35–40%
of SWCNT were represented by large aggregates of .0.75 mm
whereas 20–25% of aggregates were .0.5 mm and 35–40% had
the size range from 0.5–0.75 mm in w/t and k/o animals. This
distribution had changed markedly at day 28 after exposure in
favour of small aggregates. The ‘‘cutting’’ pattern was different in
w/t and k/o animals: a ,2-fold increase for aggregates ,0.5 mm,
mostly at the expense of the decreased amount of large aggregates,
was observed in the lungs of w/t mice whereas these changes in
the SWCNT size distribution were much less pronounced in MPO
k/o mice (Fig. 4b, c). This suggests that MPO was involved in the
cutting of SWCNT into smaller fragments - in accord with our
previous in vitro experiments [14].
Raman spectroscopic evaluation of defects in SWCNT in
the lungs of w/t and MPO k/o mice
MPO-driven biodegradation occurs via oxidative modification
of SWCNT with the appearance of characteristic defects
detectable by Raman spectroscopy [14]. Therefore, we utilized
two different Raman spectroscopic techniques to determine
whether these oxidation-associated defects could be detected in
the samples of the lung from exposed mice. First, we performed
Raman spectroscopy after solubilization of the lung tissue. To
assess oxidative biodegradation of SWCNT, the D-band/G-band
ratios were calculated, whereby an increase in the ratio indicates
oxidative degradation [15,16]. Typical Raman spectra document-
ing the signals from non-oxidized SWCNT with a pronounced G
band and a very weak D-band were recorded on day 1 post-
exposure resulting in low D-band/G-band ratios for both w/t and
MPO k/o animals (Fig. 5a). On day 28 post-exposure, the D-
band/G-band ratio remained almost unchanged for the samples
from k/o animals whereas an ,2-fold increase was found in the
lungs of w/t mice. Next, we obtained Raman maps of ten different
areas that contained SWCNT within each lung tissue section.
Fig. 5b shows examples of bright-field images of samples from w/t
and MPO k/o mice, respectively, at day 1 post-exposure, with a
red box indicating the area where the Raman maps were acquired;
(5c, 1–4) shows typical Raman maps obtained based on the
clusters (5c, 5–8) per pixel. These bright-field images and Raman
maps were generated for every sample on days 1 and 28 after the
SWCNT exposure. SWCNT degradation increased over time.
Importantly, 28 days post exposure there was a significant
difference (p = 0.0277) between the D-band/G-band ratios of the
SWCNT indicative of a markedly higher SWCNT degradation in
w/t mice than in MPO k/o animals (Fig. 5d).
While the difference in clearance of SWCNT from the lungs of
w/t and MPO k/o mice was significant, it is also obvious that
additional, yet to be identified, factors contribute to biodegrada-
tion and elimination of SWCNT. Indeed, SWCNT clearance
occurred, although at a lower rate, in MPO k/o animals.
Figure 2. Changes in the content of collagen and average thickness of alveolar connective tissue in the lungs of w/t and MPO k/o
mice at days 1 and 28 after pharyngeal aspiration of SWCNT. a. Accumulation of collagen in the lung of w/t or MPO k/o mice. Mean 6 SEM
(n = 6 mice/group). *p,0.05, vs control PBS-exposed mice, # p,0.05, vs w/t mice 28 days post exposure. b. Morphometric assessments of average
thickness of alveolar connective tissue in the lung of w/t or MPO k/o mice. Mean 6 SEM (n= 6 mice/group). *p,0.05, vs control PBS-exposed mice,
# p,0.05, vs w/t 28 days post exposure.
doi:10.1371/journal.pone.0030923.g002
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Contribution of other heme-peroxidases to the clearance of
SWCNT is quite possible. Degradation of SWCNT by MPO
during the peroxidase cycle whereby the reaction with H2O2 yields
a reactive intermediate, compound I, which oxidizes chloride by a
single 2-electron transfer to produce the hypochlorous acid
(HOCl). Both oxidants – reactive MPO intermediates and
hypochlorous acid – are involved in the oxidative degradation of
nanotubes [14] due to the breakage of C-C and C-H bonds [17].
Reactive intermediates can be also generated by other heme-
peroxidases such as eosinophil peroxidase, lactoperoxidase,
thyroid peroxidase as well as by hemoproteins with peroxidase
activity (hemoglobin, myoglobin, cytochromes P450). In fact, the
ability of horseradish peroxidase (HRP) and lactoperoxidase to
oxidatively biodegrade SWCNT in vitro has been documented
[11,12,18]. While it is possible that alternative peroxidase
pathways may participate in pulmonary biodegradation of
SWCNT the results of the current study - demonstrating a
significantly lower clearance of SWCNT from the lungs of MPO
k/o mice vs w/t animals - are supportive of the essential role of
MPO in this process. While this study utilized SWCNT, it is highly
likely that multi-walled carbon nanotubes, fullerenes, graphene
and other carbonaceous particles may also undergo MPO-
catalyzed modifications and degradation [19].
In contrast to in vitro incubation systems, non-covalent coating of
SWCNT with proteins and lipids in vivo [20,21] occurring during
their interactions with components of biofluids will inevitably
affect recognition patterns and metabolic pathways of the particles.
Our recent studies indicate that in the lung, SWCNT are
effectively coated with the major surfactant lipids and proteins.
Hence, the nature of the nanomaterial ‘‘coronation’’ by proteins
and/or lipids may impact on the degree of recognition and
biodegradation by immune-competent cells.
The major bactericidal function of MPO via oxidative attack on
pathogens has been well characterized [22,23]. The ability of
MPO to oxidatively modify organic xenobiotics and drugs has
been also documented [24,25]. Here, we describe a hitherto
unknown role of MPO in the body to oxidatively biodegrade
carbonaceous particles, specifically SWCNT. One can presume
that this is one of the essential and very ancient catalytic roles of
the enzyme aimed at oxidative degradation and clearance of
different types of carbonaceous materials to which animals and
humanoids have been exposed from primordial times – such as
Figure 3. Assessment of the volume of SWCNT aggregates in the lung tissue sections from w/t and MPO k/o mice. a. Representative
images of the lung tissue sections. Insert - higher magnifigation (2.56 zoom) of a field illustrating the presence of SWCNT (green punctuate spots
pointed by white arrows). b. Quantitation of SWCNT aggregates (SWCNT volume/total lung volume) using their specific absorbance (750–850 nm),
* p,0.05, vs w/t 1 day post exposure, # p,0.05, vs w/t 28 days post exposure. c. Assessment of SWCNT aggregates - number per microscopic field -
using an automated IN Cell Analyser 1000 microscope, * p,0.05, vs w/t 1 day post exposure, # p,0.05, vs w/t 28 days post exposure.
doi:10.1371/journal.pone.0030923.g003
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particles generated by intentional (e.g., during cooking of food or
technological high temperature processing of metals and other
materials) or unintentional (forest fires, volcano eruptions)
exposures. With the advent of nanotechnologies, health concerns
prompted exploration of endogenous metabolic pathways compe-
tent in clearance of these notoriously biopersistent, inflammogenic
and genotoxic, hence potentially high risk materials, including
SWCNT. The current work demonstrates that MPO is involved in
SWCNT degradation in vivo thus offering new opportunities for
controlled regulation of SWNT’s ‘‘life-span’’ in tissues and
circulation.
Methods
Preparation and characterization of SWCNT
SWCNT (CNI Inc., Houston, TX) produced by the high
pressure CO disproportionation process (HiPco) technique [26]
employing CO in a continuous-flow gas phase as the carbon
feedstock and Fe(CO)5 as the iron-containing catalyst precursor,
and purified by acid treatment to remove metal contaminates [27]
were used in the study. Chemical analysis trace metal (iron) in
SWCNT was performed at the Chemical Exposure and
Monitoring Branch (DART/NIOSH, Cincinnati, OH) using
nitric acid dissolution and inductively coupled plasma-atomic
emission spectrometry (ICP-AES). Analysis revealed that SWCNT
comprised of 0.23 weight % iron. SWCNT were routinely tested
for bacterial endotoxin (LPS) contamination using the endpoint
chromogenic LAL method, as previously described [28]. The
mean diameter and surface area of SWCNT was 1–4 nm and
1040 m2/g. Surface area was determined by Brunauer, Emmett,
and Teller (BET) analysis, and diameter and length was measured
by TEM.
The chemical cutting of SWCNT was performed as reported
previously [29]. Purified SWCNT were dispersed in 3:1 mixture of
Figure 4. Evaluation of SWCNT size distribution in solubilized lungs of w/t and MPO k/o mice at days 1 and 28 post exposure by
transmission electron microscopy. a. Typical TEM images of SWCNT after solubilization of the lung tissue. b. Size distribution of SWCNT present in
the lung at days 1 and 28 post exposure. * p,0.05, vs w/t 1 day post exposure, # p,0.05, vs w/t 28 days post exposure. c. Changes in size
distribution of SWCNT at day 28 post exposure compared to day 1 post exposure.
doi:10.1371/journal.pone.0030923.g004
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concentrated H2SO4 and 30% aqueous H2O2 and sonicated in
ultrasonic bath (Branson 1510 SonifierH, output power of 70 W at
40 KHz) for 24 hrs at 0uC. The dispersion was then heated to
70uC for 10 min for ‘‘polishing’’ the nanotubes. This solution was
then diluted 10-fold by deionized water and filtered through PTFE
membrane (100 mm pore size). The collected sample was
thoroughly washed with deionized water and vacuum dried at
110uC for 30 min. Obtained short SWCNT were dispersed in
25 mM HEPES buffer (pH 7.4; containing 150 mM NaCl) by
sonication. For purity assessment and characterization of SWCNT
we used several standard analytical techniques. TEM was
employed to determine the length distribution (Fig. S1a). Raman
spectroscopy was implemented to visualize the D and G bands
(Fig. S1b). Diffuse reflectance infrared Fourier Transform
spectroscopy (DRIFTS) was also performed (methods S1, Fig.
S1c).
Animals
Specific pathogen-free adult (8–10 week) female C57BL/6 mice
(w/t) and B6.129X1-MPO mice (MPO k/o) were supplied by
Jackson Lab (Bar Harbor, ME) and weighed 20.061.9 g when
used. C57BL/6 mice are widely used as background for the
Figure 5. Raman spectroscopic evaluation of ‘‘oxidative’’ defects in SWCNT present in the lungs of w/t and MPO k/o mice at days 1
and 28 post exposure using single point Raman spectroscopy or Raman mapping of different areas within the tissue samples. a. D-
band/G- band ratios for single point Raman spectra obtained from samples at days 1 and 28 post exposure. * p,0.05, vs w/t 1 day post exposure,
# p,0.05, vs w/t 28 days post exposure. Insert – typical Raman spectra (excitation at 633 nm) of solubilized lungs of w/t mice at days 1 and 28 post
exposure. b–d. Raman mapping of SWCNT in different areas of the lung sections. b. Examples of bright-field images with a red box indicating the area
where 32632 Raman spectra were acquired. Note that the sizes of the acquired areas were different at day 1 and day 28 (20 mm620 mm and
10 mm610 mm respectively), as significantly smaller SWCNT aggregates were detected at day 28 in w/t mice and the scanned areas were adjusted
accordingly. c. Raman maps (excitation at 473 nm excitation) with examples of spectra corresponding to each of the clusters. d. D-band/G-band ratios
for Raman spectral maps obtained from the lung of w/t and MPO k/o mice at days 1 and 28 post exposure.
doi:10.1371/journal.pone.0030923.g005
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development of transgenic/knockout models as well as for safety
and efficacy testing. B6.129X1 MPO-deficient mice were created
by targeted disruption of the MPO gene in RW4 embryonic stem
cells. The mutant allele was transferred to the C57BL/6J
background using a marker assisted screening protocol. Polymor-
phisms between parental strain 129/SvJ and recipient strain
C57BL/6J were screened at approximately 20 cM intervals to
select for the mice containing the most C57BL/6J composition.
Heterozygous mice (approximately 91% C57BL/6J) were inter-
crossed and all experiments used 2–6-month-old female knockout,
heterozygote, and wild-type littermate animals. The absence of
MPO in MPO k/o mice was proved by Northern blot or Western
blot analysis of bone marrow. Neutrophils and monocytes from
both peripheral blood and bone marrow of MPO k/o animals
failed to exhibit endogenous peroxidase activity. In contrast,
eosinophils, which possess eosinophil peroxidase, demonstrated
peroxidase staining [30].
Animals were housed one mouse per cage receiving HEPA
filtered air in AAALAC-approved NIOSH animal facilities. All
animals were acclimated in the animal facility under controlled
temperature and humidity for one week prior to use. Animals were
supplied with water and certified chow 7913 (Harlan Tekland,
Indianapolis, IN) ad libitum, in accordance with guidelines and
policy set forth by the Institute of Laboratory Animals Resources,
National Research Council. All animal studies were carried in
compliance with the policies of the Institute of Laboratory Animal
Resources (National Research Council) and the experimental
protocol (#07-AS-M-010), approved by the National Institute for
Occupational Safety and Health (NIOSH) Institutional Animal
Care and Use Committee.
Experimental Design
Experimental protocols for the present study included pharyn-
geal aspiration exposure of w/t and MPO k/o mice to 40 mg/
mouse SWCNT, while the corresponding control mice were
administered sterile Ca2++Mg2+-free phosphate-buffered saline
(PBS) vehicle. Particulate instillation was performed as described
in Methods S1. Mice were sacrificed on days 1 and 28 following
the exposure. Inflammation was evaluated by total cell counts, cell
differentials, and accumulation of cytokines in the bronchoalveolar
lavage (BAL) fluid. Fibrogenic responses to exposed materials were
assessed by morphometric measurements and collagen deposition.
Obtaining bronchoalveolar lavage (BAL) from mice
Mice were sacrificed with intraperitoneal injection of sodium
pentobarbital (.100 mg/kg) and exsanguinated. The trachea was
cannulated with a blunted 22 gauge needle, and BAL was
performed using cold sterile PBS at a volume of 0.9 ml for first
lavage (kept separate) and 1.0 ml for subsequent lavages.
Approximately 5 ml of BAL fluid per mouse was collected in
sterile centrifuge tubes. Pooled BAL cells for each individual
mouse were washed in PBS by alternate centrifugation (8006g,
10 min, 4uC) and resuspened. BAL aliquots were frozen at 280uC
until processed. Procedures used for BAL cell counting and
cytokine analysis is described in Methods S1.
Sirius red staining
The distributions of type I and type III collagen in the lung
tissue were determined by morphometric evaluation of the Sirius
red-stained sections [3]. To identify collagen fibers under the
microscope, deparaffinized and dehydrated lung sections were
stained with F3BA/picric acid for 1–2 h, washed with 0.01N HCL
for 1 min, and counterstained with Mayer’s hematoxylin for 2 min
[31]. Type I and III collagen stained by Sirus red was visualized,
and 6 randomly selected areas were scored under polarized
microscopy and average thickness of Sirius red positive connective
tissues in the alveolar wall was quantitatively measured. Volume
and surface density was measured using standard morphometric
analyses of points and intercept counting [32]. Average thickness
of the Sirius red positive connective tissues of the alveolar wall was
computed from two times the ratio of volume density of points to
the surface density of the alveolar wall.
Lung collagen measurements
Whole lungs from each mouse were homogenized in 0.7 ml of
0.5 M acetic acid containing pepsin (Accurate Chemical and
Scientific Corporation, Westbury, NY) with 1:10 ratio of pepsin:
tissue wet weight. Total lung collagen content was determined by
quantifying total soluble collagen using the Sircol Collagen Assay
kit (Accurate Chemical and Scientific Corporation, Westbury,
NY).
Solubilization of lungs
Lungs were homogenized using Biospec Products Inc, OK,
USA tissue homogenizer in 500 mL of deionized water. After
homogenization, 1% SDS was added and samples were heated to
100uC for 10 min. This was followed by sonication using the
ultrasonic benchtop cleaner (Branson 2510, output power of 70 W
at 40 KHz) for 10 min. After cooling the contents to room
temperature, Tris-HCl buffer (final concentration 30 mM)
(pH 8.0) was added. Finally, an 18 hrs incubation of the material
with 100 mg/mL of proteinase K at 50uC was undertaken to
completely solubilize the lungs.
Raman maps
Raman maps of lung tissue sections were acquired using an
NTEGRA Spectra microscopic system integrated with Raman
spectrometer (NT-MDT, Russia) 473 nm cobalt laser operated at
10%, 1006 oil objective, 2 s exposure of static spectra centred at
2070 cm21. Ten maps (32632 points, 20 mm620 mm or
10 mm610 mm) were recorded for each tissue section. The Raman
maps were then imported into Matlab 7 (The Mathworks, USA)
for analysis, where all of the spectra were normalized, smoothed,
baseline corrected and K-means clustering was carried out.
Raman spectroscopy of solubilized lung tissue as well as
transmission electron microscopy was performed as described in
Methods S1.
Image analysis
Lung preparation for microscopic evaluation was performed as
described in Methods S1. Two color images were collected from
mounted sections of lung using a Hamamatsu Orca ER cooled
CCD camera (Hamamatsu, Bridgewater, NJ) on a Nikon 90i
upright microscope (Melville, NY), equipped with a high speed
linear encoded xy stage (Prior Scientific, Rockland, MA), and
fluorescence imaging and bright field imaging capabilities. The
motorized stage coupled with Elements software (Nikon NIS,
Melville, NY) allows collection of large area images which consist
of multiple stitched and aligned frames. Each image was a 10610
image field at 106magnification. To collect the image of the lung
tissue the autofluorescent signal from the paraffin embedment was
detected using 530 nm excitation and 560–600 nm emission. To
visualize nanotubes sections were illuminated with white light and
blocking filter (750–840 nm transmission) was placed between the
specimen and the camera. In this conditions nanotubes selectively
absorbing light in the range 750–800 nm were seen as black spots.
For image processing, the area of the lung in the section profile
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was used to outline the lung, and the autofluorescent signal was
used to threshold and generate tissue area measurements in each
section. The same section profile region was overlaid on the
nanotube image and a dark objects thresholded to generate an
area measurement of the nanotubes within the lung. In the final
images shown in Fig. 3a the lung tissue is shown in red, the tube
image was inverted (such that the tubes are now bright) and
pseudocolored green. The scale bar is 1 mm.
Detection of SWCNT aggregates
Unstained paraffin embedded lung tissue sections from MPO k/
o and w/t mice were scanned using the IN Cell Analyser 1000
high content screening and analysis system to distinguish between
the organic tissue and the inorganic SWCNT (under bright field
imaging settings). Optically detectable SWCNT aggregates were
counted and their distribution and sizes were calculated using IN
Cell Investigator software.
Statistics
The results are presented as means 6 S.D. values from at least
three experiments, and statistical analyses were performed by one-
way ANOVA. The statistical significance of differences was set at
p,0.05.
Disclaimer
The findings and conclusions in this report are those of the
authors and do not necessarily represent the views of the National
Institute for Occupational Safety and Health.
Supporting Information
Figure S1 Characterization of SWCNT employed in the
study. a. Histogram detailing the length distribution of SWCNT.
The mean length was determined to be 6766329 nm employing a
sample size of 100. The insert depicts a TEM micrograph (500 nm
scale bar) for the SWCNT sample. b. Raman spectrum for
SWCNT; the D- and G- bands are marked on the spectrum. c.
The spectrum obtained utilizing diffuse reflectance infrared
Fourier Transform spectroscopy (DRIFTS). The unit for the
ordinate axis is Kubelka-Munk (KM).
(TIF)
Methods S1 Supplemental methods.
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